# Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers

> **NCT04477369** · PHASE1 · UNKNOWN · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 28 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** DWJ1439
- **DRUG:** DWJ1464
- **DRUG:** DWC202003
- **DRUG:** DWC202004

## Key facts

- **NCT ID:** NCT04477369
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-06
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-09
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477369, "Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04477369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*